VEGF / VEGFA / VEGF165 Protein (recombinant human/Cynomolgus )

VEGF / VEGFA / VEGF165 Protein (recombinant human/Cynomolgus )
Item number Size Datasheet Manual SDS Delivery time Quantity Price
E-PKSH031978.20 20 µg -

7 - 16 business days*

533.00€
E-PKSH031978.100 100 µg -

7 - 16 business days*

1,070.00€
 
Activity: Measured in a cell proliferation assay using human umbilical vein endothelial cells... more
Product information "VEGF / VEGFA / VEGF165 Protein (recombinant human/Cynomolgus )"
Activity: Measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC).The ED50 for this effect is typically 4-16 ng/mL. Protein Construction: A DNA sequence encoding the human VEGF165 isoform (P15692-4) (Met1-Arg191) was expressed. Human and Cynomolgus VEGF165 sequences are identical. Sequence: Met 1-Arg191. Endotoxin: < 1.0 EU per µg as determined by the LAL method. Apparent Molecular Mass: 20 and 22 kDa. Protein function: Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy Protein function: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. Binding to NRP1 receptor initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development. [The UniProt Consortium]
Keywords: VPF, VEGF, VEGFA, VEGF-A, Vascular permeability factor, Vascular endothelial growth factor A, Recombinant Human / Cynomolgus VEGF / VEGFA / VEGF165 Protein
Supplier: Elabscience
Supplier-Nr: E-PKSH031978

Properties

Conjugate: No
Host: Human cells
Species reactivity: human
MW: 19.2 kD
Format: Lyophilized

Handling & Safety

Storage: -80°C
Shipping: +4°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "VEGF / VEGFA / VEGF165 Protein (recombinant human/Cynomolgus )"
Write a review
or to review a product.
Viewed